Founded in 1996, Dalian Zhenao Group is primarily engaged in the research and development of biotechnology, gene technology, and the manufacturing of bio-pharmaceuticals and health products. Its total investment accounts for 2.16 billion yuan. Zhenao Group has China's largest nucleic acid manufacture base, with an annual production capacity of 15 billion yuan.
